Merative
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Merative L.P., formerly IBM Watson Health, is an American medical technology company that provides products and services that help clients facilitate medical research, clinical research, real world evidence, and healthcare services through the use of artificial intelligence, data analytics, cloud computing, and other advanced information technology. Merative is owned by Francisco Partners, an American private equity firm headquartered in San Francisco, California. In 2022, IBM divested and spun-off their Watson Health division into Merative. , it remains a standalone company headquartered in Ann Arbor with innovation centers in Ireland, Hyderabad, Bengaluru, and Chennai.
Merative L.P., formerly IBM Watson Health, is an American medical technology company that provides products and services that help clients facilitate medical research, clinical research, real world evidence, and healthcare services through the use of artificial intelligence, data analytics, cloud computing, and other advanced information technology. Merative is owned by Francisco Partners, an American private equity firm headquartered in San Francisco, California. In 2022, IBM divested and spun-off their Watson Health division into Merative. , it remains a standalone company headquartered in Ann Arbor with innovation centers in Ireland, Hyderabad, Bengaluru, and Chennai. ==History== Thomson Healthcare was a division of Thomson Corporation until 2008, when, following Thomson's merger with Reuters, it became the healthcare unit of Thomson Reuters. On April 23, 2012, Thomson Reuters agreed to sell it to Veritas Capital for US$1.25 billion. On June 6, 2012, the sale was finalized and the new company, Truven Health Analytics, became an independent organization solely focused on healthcare. IBM Corporation acquired Truven Health Analytics on February 18, 2016, and merged it with IBM's Watson Health unit. Truven Health Analytics provided comprehensive healthcare data and analytics services. The company name Truven is a portmanteau of the words "trusted" and "proven". In January 2022, IBM announced the sale of part of the Watson Health assets, including Truven to Francisco Partners for a reported $1 billion. On June 30, 2022, Francisco Partners announced the completion of acquiring Watson Health and launched a healthcare data company named Merative.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375971779 under CC BY-SA 4.0; modifications have been made.